Company profile

Magentiq Eye, Ltd.

Magentiq Eye, Ltd. has 4 AI-enabled medical devices on the FDA list. The first decision was on July 25, 2023 and the most recent on April 3, 2026 (MAGENTIQ-COLO (ME-APDS)). Its most common review panel is Gastroenterology-Urology (4 devices).

4AI devices

2023First decision

2026Latest decision

1Specialties

Per year

202320252026

Magentiq Eye, Ltd. AI devices per year: 2023 1, 2025 2, 2026 1

By specialty

Gastroenterology-Urology4

Related guides

Top gastroenterology-urology devices

Timeline

April 3, 2026 · 510(k) K260724MAGENTIQ-COLO (ME-APDS) · Gastroenterology-Urology · QNP
October 3, 2025 · 510(k) K252178MAGENTIQ-COLO (ME-APDS) · Gastroenterology-Urology · QNP
January 24, 2025 · 510(k) K244023MAGENTIQ-COLO (ME-APDS) · Gastroenterology-Urology · QNP
July 25, 2023 · 510(k) K223473ME-APDS; MAGENTIQ-COLO · Gastroenterology-Urology · QNP